October 8, 2011 by staff
Diabetes-cholesterol Pill, Breast cancer and bladder cancer have been linked to a diabetes drug that is currently under development, the U.S. Food … Read moreand Drug Administration says. A pill for diabetes, cholesterol has been approved by the Food and Drug Administration to combat diabetes and high cholesterol.
Juvisync, developed by Merck & Co. Inc., will be launched within weeks, reports the Associated Press. Merck combines type 2 diabetes pill Januvia with Zocor, a former Merck’s success in the class used for cholesterol drugs called statins.
“This provides a way to simplify their regimen and improve compliance,” said Dr. Susan Spratt, an endocrinologist at Duke University Medical Center, reported the Associated Press.
Many of the patients more than 25 million U.S. diabetes also have high cholesterol, in part because the two conditions are often associated with being overweight.
The combination pill will be sold for the same price as Januvia alone, and 215 per month, the Associated Press reports. Generic versions of the drug and costs about 30 per month.
Points will be available in six different doses, to accommodate patients with different levels of cholesterol and diabetes, according to the Associated Press. Common side effects of the drug include nasal congestion and sore throat pain, headache, muscle and stomach.
Many diabetic patients are taking six or more pills a day, including the different types of diabetes pills, blood pressure and high cholesterol, Spratt says the Associated Press. This makes patients out of pocket costs for medications and diabetes testing supplies even more.
Please feel free to send if you have any questions regarding this post , you can contact on
Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.